Abdul-Razak, HH;
Rocca, CJ;
Howe, SJ;
Alonso-Ferrero, ME;
Wang, J;
Gabriel, R;
Bartholomae, CC;
... Yanez-Munoz, RJ; + view all
(2018)
Molecular Evidence of Genome Editing in a Mouse Model of Immunodeficiency.
Scientific Reports
, 8
, Article 8214. 10.1038/s41598-018-26439-9.
Preview |
Text (Published article)
Abdul-Razak_Molecular_evidence.pdf - Published Version Download (3MB) | Preview |
Preview |
Text (Supplementary information)
Abdul-Razak_Molecular_evidence_Suppl.pdf Download (1MB) | Preview |
Abstract
Genome editing is the introduction of directed modifications in the genome, a process boosted to therapeutic levels by designer nucleases. Building on the experience of ex vivo gene therapy for severe combined immunodeficiencies, it is likely that genome editing of haematopoietic stem/progenitor cells (HSPC) for correction of inherited blood diseases will be an early clinical application. We show molecular evidence of gene correction in a mouse model of primary immunodeficiency. In vitro experiments in DNA-dependent protein kinase catalytic subunit severe combined immunodeficiency (Prkdc scid) fibroblasts using designed zinc finger nucleases (ZFN) and a repair template demonstrated molecular and functional correction of the defect. Following transplantation of ex vivo gene-edited Prkdc scid HSPC, some of the recipient animals carried the expected genomic signature of ZFN-driven gene correction. In some primary and secondary transplant recipients we detected double-positive CD4/CD8 T-cells in thymus and single-positive T-cells in blood, but no other evidence of immune reconstitution. However, the leakiness of this model is a confounding factor for the interpretation of the possible T-cell reconstitution. Our results provide support for the feasibility of rescuing inherited blood disease by ex vivo genome editing followed by transplantation, and highlight some of the challenges.
| Type: | Article |
|---|---|
| Title: | Molecular Evidence of Genome Editing in a Mouse Model of Immunodeficiency |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/s41598-018-26439-9 |
| Publisher version: | http://dx.doi.org/10.1038/s41598-018-26439-9 |
| Language: | English |
| Additional information: | Open Access: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10050124 |
Archive Staff Only
 |
View Item |
